A medical team in the United States said on Thursday that they had successfully repaired a human ear using the patient's own tissue to build a 3D bioimplant, a groundbreaking method that they hope can one day be used to cure others with a rare birth condition.
The operation was part of an early-stage clinical experiment to assess the implant's safety and efficacy in persons with microtia, a condition in which the external ear is tiny and poorly shaped.
The implant, known as AuriNovo, was created by 3DBio Therapeutics, and the procedure was performed by Arturo Bonilla, founder and director of the Microtia-Congenital Ear Deformity Institute in San Antonio, Texas.
"As a physician who has treated thousands of children with microtia from across the country and around the world, I am inspired by what this technology may mean for microtia patients and their families," Bonilla stated.
He hopes the implant may one day replace the existing therapy for microtia, which requires transplanting cartilage from a patient's ribs or reconstructing the outer ears with synthetic materials such as porous polyethylene (PPE).
The method entails creating a blueprint by 3D scanning the patient's opposite ear, then extracting a sample of the patient's ear cartilage cells and growing them to an appropriate number.
These cells are combined with bio-ink made of collagen and molded into an outer ear. The implant is encased in a printed, biodegradable shell that provides immediate support but eventually dissolves in the patient's body.
The implanted ear is expected to grow over time, taking on the natural appearance and feel of a normal ear, including flexibility.
The clinical research, which is being done in California and Texas, is expected to enroll 11 participants.